Duffy Farifteh Firoozmand, Narrow William, West Joyce C, Fochtmann Laura J, Kahn David A, Suppes Trisha, Oldham John M, McIntyre John S, Manderscheid Ronald W, Sirovatka Paul, Regier Darrel
American Psychiatric Institute for Research and Education, 1000 Wilson Blvd, Suite 1825, Arlington, Virginia 22209, USA.
Psychiatr Q. 2005 Fall;76(3):213-30. doi: 10.1007/s11126-005-2975-4.
The staff of the American Psychiatric Association (APA), the American Psychiatric Institute for Research and Education (APIRE), and a national panel of experts in bipolar disorder and practice guideline development have collaborated to generate a set of quality of care indicators for the pharmacologic and psychosocial treatment of bipolar disorder. The indicators were derived from APA's evidence-based Practice Guideline for the Treatment of Patients with Bipolar Disorder, 2002 (1) and the Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder, 2000 (2) These quality indicators can be used for quality monitoring, benchmarking, and quality improvement efforts across health plans, systems of care, and health care providers to improve quality and outcomes of care for patients with bipolar disorder.
美国精神病学协会（APA）、美国精神病学研究与教育学会（APIRE）的工作人员，以及双相情感障碍和实践指南制定方面的全国专家小组共同合作，制定了一套用于双相情感障碍药物治疗和心理社会治疗的护理质量指标。这些指标源自美国精神病学协会2002年发布的《双相情感障碍患者治疗循证实践指南》（1）以及2000年发布的《专家共识指南系列：双相情感障碍的药物治疗》（2）。这些质量指标可用于跨健康计划、护理系统和医疗服务提供者的质量监测、基准对比和质量改进工作，以提高双相情感障碍患者的护理质量和治疗效果。
